blog

Protein aggregation is a critical challenge in biotherapeutic manufacturing, impacting product quality, efficacy, and patient safety. Often undetected until later stages, aggregation can derail even the most meticulously developed monoclonal antibodies (mAbs), peptides, […]

In the high-stakes world of biotherapeutics, even the most promising drugs can face setbacks, not because of efficacy or safety issues, but due to overlooked gaps […]

The era of one-size-fits-all medicine is rapidly being replaced by personalized medicine, where treatments are tailored to the unique genetic makeup of each patient. Leading this […]